primary progressive aphasia market

Primary Progressive Aphasia (PPA) is a rare neurological disorder that results from the damages to the areas of brain responsible for communication (language and speech). Affected patients experience progressive loss of their ability to speak, read, write or understand clearly.

Through DelveInsight’s newsletter, we bring to you the current trends of the Primary Progressive Aphasia market, epidemiology and treatment landscape. Know more of what is cooking in the domain, read about recent happenings, key pharmaceutical companies in the PPA market, key collaborations and deals ongoing, and treatment breakthroughs in the domain. The most prominent feature is the gradual loss of language skills—speaking, understanding speech, reading, and writing.

Fill up a simple form and receive the latest on ongoing R&D, and a lot more about the disease, underlying causes, treatment options, and unmet needs in the PPA market directly in the email box. Primary Progressive Aphasia (PPA) is a rare neurological condition that affects a person’s ability to use and understand language. It is classified as a type of frontotemporal dementia, although it differs from more common forms of dementia like Alzheimer’s disease in that memory and other cognitive functions may remain relatively intact in the early stages.

Subscribe to DelveInsight's mailing list and never miss an update on pharmaceutical and healthcare industry.

Keep in touch.